MEK inhibitor
MEK inhibitor is a type of drug that inhibits the mitogen-activated protein kinase kinase (MEK). It is used in the treatment of various types of cancer, including melanoma, lung cancer, colorectal cancer, and thyroid cancer.
Mechanism of action[edit | edit source]
MEK inhibitors work by blocking the action of a protein called MEK, which is part of a pathway that helps cells to divide and survive. By inhibiting MEK, these drugs can stop cancer cells from growing and dividing.
Types of MEK inhibitors[edit | edit source]
There are several types of MEK inhibitors, including:
Each of these drugs has been approved by the Food and Drug Administration (FDA) for use in certain types of cancer.
Side effects[edit | edit source]
Like all drugs, MEK inhibitors can cause side effects. These can vary from person to person, but may include:
See also[edit | edit source]
MEK inhibitor Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD